Buy IBM (IBM) into Tuesday’s report. The options market is pricing a huge move, and the stock has been stuck in a tight range
Ahead of General Motors earnings, here’s what Barchart data says comes next for GM stock
General Motors (GM) shares have extended gains in recent weeks, but options traders believe they will pare back some of them after the earnings
Options Action: SpaceX reports earnings Tuesday
CNBC’s Oliver Renick joins ‘Halftime Report’ to discuss the latest moves in SpaceX options.
Here’s How Much SpaceX Stock Is Expected to Move After Earnings
SpaceX is set to report earnings tomorrow for the second time since going public back in June, with traders anticipating a big move in
Elon Musk promises $10 billion in SpaceX stock to every American child—but what’s the catch?
Elon Musk promises every American child a free SpaceX share in 2027. Here’s what the $10.7 billion pledge means, the benefits, risks, and unanswered
Gold and silver investments: Should you buy physical gold, ETFs or mutual funds? Liquidity, costs and risks compared
Investors can choose from physical gold and silver, digital gold, ETFs, mutual funds, Sovereign Gold Bonds and Electronic Gold Receipts. Each option differs in
How a possible dead-cat bounce may trigger a 135% options payout for Baidu (BIDU) stock
From the looks of things, Baidu (BIDU) is a name to avoid and for good reason. It’s one of the tech-related names that fully
Cboe and NYSE Roll Out Pre-Market Trading for Key Stock Options
Cboe Global Markets launched extended trading hours for options on 24 stocks and five exchange-traded funds on Monday, 19 October, giving traders access before
We’re buying more of a beaten-up stock before another overhang is lifted
We are buying 35 shares of Boeing at roughly $191.16. Following the trade, Jim Cramer’s Charitable Trust will own 620 shares of BA, increasing
Stock market today: Dow up, Nasdaq rallies; SanDisk surges as this biotech play tests entry (live coverage)
The Dow Jones index reverses higher as tech stocks jump Monday. Amazon and Nvidia rebound while a biotech stock tests a buy point.